secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2025-09-04T23:59:59+00:00
Accession:  0001213900-25-084498
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

CERo Therapeutics receives Nasdaq delisting notice for equity shortfall, appeals
--------------------------------------------------------------------------------

- Nasdaq staff determined company fails minimum $2.5M stockholders' equity requirement for continued listing.
- Trading suspension and delisting scheduled for September 8, 2025, unless hearing stays action.
- Company requested hearing on September 3, 2025, to appeal determination and present compliance plan.
- Plan may include public or private financing to increase equity; no assurance of success.
- Company subject to mandatory hearings panel monitor until May 7, 2026, after prior non-compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025084498/0001213900-25-084498-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025084498/ea0255967-8k_cero.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-084498

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer